GlassScriptPhysician profile
Frank S Lee
NPI 1083661995
$6,842.71
in general payments reported to CMS, 2019-2025
10 companies · $294 in 2025
The $294 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,852 · 2020: $1,352 · 2021: $251 · 2022: $55.61 · 2023: $2,038 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,369 · Food and Beverage: $963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,368.76 |
| Food and Beverage | $963.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $2,636.29 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $2,192.23 | 2019-2025 | Comprehensive Shoulder System, Juggerknotless Soft Anchor, Choice Instruments |
| Arthrex, INC. | $1,240.39 | 2019-2023 | |
| Stryker Corporation | $328.58 | 2019-2022 | |
| Smith+Nephew, INC. | $139.04 | 2019 | |
| Nuvasive, INC. | $120.37 | 2021 | |
| Catalyst Orthoscience | $82.00 | 2025 | |
| Anika Therapeutics, INC. | $41.29 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $38.00 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $24.52 | 2025 | Exparel, Iovera, Zilretta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.